-0.12 | -0.85%
| Price and Volume | |
|---|---|
| Recent Price | 14.07 |
| 52 Week High | 16.15 |
| 52 Week Low | 8.73 |
| Avg. Daily Vol. (Mil) | 0.04 |
| Beta (3 year) | 0.88 |
| Share Related Items | |
| Mkt Cap (Mil) | 246.83 |
| Shares Out (Mil) | 17.54 |
| Float (Mil) | 15.32 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 13.00 |
| Current Ratio | 14.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.17 |
| Price/Book | 1.69 |
| Price/Cash Flow | 566.10 |
| Per Share Data | |
| Earnings | -0.27 |
| Sales | 3.38 |
| Book Value | 8.32 |
| Cash Flow | 0.02 |
| Business Summary | |
|---|---|
| SurModics, Inc. is a provider of drug delivery and surface modification technologies to the healthcare industry. | |
| General Information | |
| 9924 West 74th Street
Eden Prairie, MN 55344 |
|
| www.surmodics.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 113 | |
| CEO: Mr. Gary R. Maharaj | |
| Short Interest | |
| Current Month (Mil) | 0.44 |
| Previous Month (Mil) | 0.43 |
| Short Interest Ratio (Days) | 11.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -3.00 |
| Return on Investments | -3.20 |
| Profitability | |
| Gross Margin | 96.10 |
| EBIT Margin | -11.70 |
| Profit Margin | -7.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet